Dassault Systemes Aktie
| 24,48EUR | -0,11EUR | -0,45% | 
WKN DE: A3CRC5 / ISIN: FR0014003TT8
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 19 789 | 20 496 | 22 523 | 23 811 | 25 000 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,24 | 0,25 | 0,25 | 0,25 | 
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 3 735 | 4 684 | 4 802 | 5 736 | 6 516 | 
| Summe Anlagevermögen | 9 229 | 9 535 | 9 459 | 8 887 | 9 030 | 
| Summe Aktiva | 12 964 | 14 219 | 14 261 | 14 623 | 15 546 | 
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7 858 | 8 008 | 6 936 | 6 777 | 6 465 | 
| Summe Eigenkapital | 5 106 | 6 211 | 7 325 | 7 846 | 9 081 | 
| Summe Passiva | 12 964 | 14 219 | 14 261 | 14 623 | 15 546 | 
Adresse
| 10, rue Marcel Dassault, 78140 Vélizy-Villacoublay | |
| Telefon | +33 (1) 61-62-61-62 | 
| Internet | http://www.3ds.com | 
Management
| Anne Asensio Vice President-Design Experience | 
| Anthony J. Costello President-Patient Cloud | 
| Bernard Charlès Executive Chairman | 
| Bruno Latchague Senior EVP-Global Field American Operations | 
| Béatrix Martinez Vice President-Investor Relations | 
| Catherine Dassault Director | 
| Claire Biot Vice President-Life Sciences Industry | 
| Dominique Florack President | 
| Elisa Prisner Executive VP-Industry, Marketing & Sustainability | 
| Florence Hu Aubigny Executive Vice President-Research & Development | 
| Florence Verzelen EVP-Industry, Marketing & Sustainability | 
| Geneviéve B. Berger Independent Non-Executive Director | 
| Grégory Abate Secretary & Senior Executive Vice President | 
| Herve Andorre Director | 
| Laurence Barthès Executive VP, Chief People & Information Officer | 
| Laurence Daures-Lescourret Lead Independent Director | 
| Marie-Hélène Habert-Dassault Director | 
| Odile Desforges Independent Director | 
| Olivier Ribet Executive Vice President | 
| Pascal Daloz Chief Executive Officer & Director | 
| Philippe Laufer Executive Vice-President-Global Brands | 
| Rouven Bergmann Chief Financial Officer & Executive Vice President | 
| Soumitra Dutta Independent Director | 
| Stéphane Declée Chief Executive Officer-ENOVIA | 
| Tanneguy de Fromont de Bouaille Director | 
| Tarek A. Sherif Chairman-Life Sciences & Healthcare | 
| Victoire de Margerie VP-Corporate Equity, Marketing & Communications | 
| Xavier Cauchois Independent Director | 
 
									 
									 
								